UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...

These tangles occur when the tau protein is altered by phosphorylation, and for many decades, the buildup of phosphorylated tau (p-tau) has been considered a biomarker of Alzheimer’s disease. You can ...

TORONTO -- Biomarkers pointing to increased risk for Alzheimer's disease were markedly reduced with the investigational cholesteryl ester transfer protein (CETP) inhibitor obicetrapib relative to ...

An Alzheimer’s “wonder drug” can delay the progression of the disease by four years, according to a new study. Researchers ...

Adopting intensive lifestyle changes can slow or stop progression of early-stage Alzheimer’s disease, according to a new ...

Groundbreaking new Alzheimer’s treatment could give patients four years of better health. Patients who participated in the ...

Adults with a father who had Alzheimer’s showed greater tau buildup, a key marker of the disease. Women in the study had more widespread tau in the ...

Long-term data presented at the Alzheimer’s Association International Conference show Leqembi can help patients stay in the ...

Dementia is a group of diseases that involve having trouble with memory, thinking, reasoning and other brain functions. It is ...

A protein long blamed for the brain damage seen in Alzheimer's disease has now been found in astonishingly high levels in healthy newborn babies, challenging decades of medical dogma.

Feb 20, 2022 3:52 pm · Updated Feb 21, 2022 11:12 am ...

The neurotransmitter glutamate is essential for regulating everything from mood to memory, but it can also encourage a toxic buildup of protein, which can contribute to Alzheimer’s and related ...